Journal Information
Most cited
119
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group
Ann Hepatol. 2024;29:101133
119
Full text access
4
Alcohol-associated liver disease: Epidemiology and managementHelena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller
Ann Hepatol. 2024;29:101162
4
Full text access
3
Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma careInah Marie C. Aquino, Devis Pascut
Ann Hepatol. 2024;29:101176
3
Full text access
2
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agentsAndrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, Varenka J Barbero-Becerra
Ann Hepatol. 2024;29:101182
2
Full text access
2
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysisShudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
2
Full text access
2
Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysisJiaying Wu, Jiayao He, Hongmei Xu
Ann Hepatol. 2024;29:101158
2
Full text access
1
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang
Ann Hepatol. 2024;29:101154
1
Full text access
1
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and EuropeansSiyu Fu, Dhamina Karim, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z. Mattos, Marco Arrese, Enrique Carrera, ... Andre Boonstra
Ann Hepatol. 2024;29:101181
1
Full text access
1
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysisWasit Wongtrakul, Natthinee Charatcharoenwitthaya, Phunchai Charatcharoenwitthaya
Ann Hepatol. 2024;29:101288
1
Full text access
1
TCD assessment in fulminant hepatic failure: Improvements in cerebral autoregulation after liver transplantationFernando M Paschoal-Jr, Ricardo C Nogueira, Karla de Almeida Lins Ronconi, Marcelo de Lima Oliveira, Kelson James Almeida, Ivana Schmidtbauer Rocha, Eric Homero Albuquerque Paschoal, Joelma Karin Sagica Fernandes Paschoal, ... Edson Bor-Seng-Shu
Ann Hepatol. 2024;29:101167
1
Full text access